Clinical Trial Update: Tirbanibulin 1% Ointment for the Treatment of Actinic Keratosis on the Back of the Hands [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating tirbanibulin 1% ointment for actinic keratosis on the back of the hands has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• tirbanibulin 1% ointment (tirbanibulin)

Snippet

Sponsor: Medical University of Graz | Conditions: Actinic Keratoses | Phase 4 | Status: WITHDRAWN